Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Transplantation|March 24, 2005
Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft functionGerd R Hetzel, Jörg Plum, Andreas Fusshöller, et al.
The Journal of Rheumatology|August 2, 2006
Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndromeChristoph Sucker, Folker Wenzel, Rainer B Zotz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2006
Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltrationGerd R Hetzel, Gediz Taskaya, Christoph Sucker, et al.
Archives of Neurology|August 16, 2006
Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disordersHelmar C Lehmann, Hans-Peter Hartung, Gerd R Hetzel, et al.
Archives of Neurology|July 13, 2006
Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disordersHelmar C Lehmann, Hans-Peter Hartung, Gerd R Hetzel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2012
Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patientsFrank-Peter Tillmann, Ivo Quack, Ana Schenk, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 27, 2008
Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?Christoph Sucker, Michael Schmitz, Gerd R Hetzel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2007
The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathiesChristoph Sucker, Firuseh Farokhzad, Christine Kurschat, et al.
International Journal of Cardiology|August 28, 2013
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal diseaseChristos Rammos, Ulrike B Hendgen-Cotta, Julia Sobierajski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 19, 2015
Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled TrialTienush Rassaf, Christos Rammos, Ulrike B Hendgen-Cotta, et al.
Pageof 2